Diffusion-weighted (DW) magnetic resonance (MR) imaging is emerging as a powerful
clinical tool for directing the care of patients with cancer. Whole-body DW imaging is almost …

An imaging biomarker that would provide for an early quantitative metric of clinical treatment
response in cancer patients would provide for a paradigm shift in cancer care. Currently …

Abstract On May 3, 2008, a National Cancer Institute (NCI)-sponsored open consensus
conference was held in Toronto, Ontario, Canada, during the 2008 International Society for …

OBJECTIVE. We examine the clinical impetus for whole-body diffusion-weighted MRI and
discuss how to implement the technique with clinical MRI systems. We include practical tips …

Objective: Application of whole body diffusion-weighted MRI (WB-DWI) for oncology are
rapidly increasing within both research and routine clinical domains. However, WB-DWI as a …

Following its success in early detection of cerebral ischemia, diffusion‐weighted imaging
(DWI) has been increasingly used in cancer diagnosis and treatment evaluation. These …

Purpose To perform a meta-analysis to evaluate the diagnostic performance of whole-body
diffusion-weighted magnetic resonance imaging (WB-DWI) technique in detection of primary …

Imaging biomarkers for the predictive assessment of treatment response in patients with
cancer earlier than standard tumor volumetric metrics would provide new opportunities to …

Purpose To determine the feasibility of whole-body diffusion-weighted (DW) magnetic
resonance (MR) imaging for assessment of treatment response in myeloma. Materials and …

Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess
tumour response to a variety of anticancer treatments. The technique is quick to perform …